Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 2, 1996, Pages 195-201

  Inoue, Takeshi ^a   Tsuchiya, Kiyoshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Atypical antipsychotic drug; Clozapine; Conditioned fear stress; Dopamine; Dopamine D4 receptors; Freezing behavior; Haloperidol; Schizophrenia

Indexed keywords

2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; EMONAPRIDE; HALOPERIDOL; IPSAPIRONE; NEUROLEPTIC AGENT; OLANZAPINE; RACLOPRIDE; SPIPERONE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEAR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; MALE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

ANIMALIA;

EID: 0030271672     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00064-0     Document Type: Article

References (42)

1. 1 antagonists. Naunyn Schmiedeberg's Arch. Pharmacol. 338:162-168; 1988.
2. 2. Bernardi, M. M.; De Souza, F.; Neto, J. P. Effects of single and long-term haloperidol administration on open field behavior of rats. Psychopharmacology (Berlin) 73:171-175; 1981.
3. 3. Brown, C. S.; Rakel, R. E.; Wells, B. G.; Downs, J. M.; Akiskal, H. S. A practical update on anxiety disorders and their pharmacological treatment. Arch. Intern. Med. 151:873-884; 1991.
4. 4. Bruhwyler, J.; Chleide, E.; Liegeois, J.-F.; Delarge, J.; Mercier, M. Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test. Pharmacol. Biochem. Behav. 36:57-61; 1990.
5. 5. Chipkin, R. E.; Latranyi, M. B. Similarity of clozapine and SCH23390 in reserpinized rats suggests a common mechanism of action. Eur. J. Pharmacol. 136:371-375; 1987.
6. 6. Chivers, J. K.; Gommeren, W.; Leysen, J. E.; Jenner, P.; Marsden, C. D. Comparison of the in vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J. Pharm. Pharmacol. 40:415-421; 1988.
7. 7. Cook, L; Davidson, A. B. Behavioral pharmacology: Animal models involving aversive control of behavior. In: Lipton, M. A.; DiMascio, A.; Killam, K. F., eds. Psychopharmacology: A generation of progress. New York: Raven Press; 1978:563-567.
8. 8. Costall, B.; Domeney, A. M.; Kelly, M. E.; Naylor, R. J.; Tomkins, D. M. Actions of ORG 5222 as a novel psychotropic agent. Pharmacol. Biochem. Behav. 35:607-615; 1990.
9. 9. Danion, J.-M.; Peretti, S.; Grange, D.: Bilik, M.; Imbs, J.-L.: Singer, L. Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers. Psychopharmacology (Berlin) 108:345-351; 1992.
10. 10. De Boer, Th.; Tonnaer, J. A. D. M.; De Vos, C. J.; Van Delft, A. M. L. Neurochemical studies with the potential antipsychotic compound trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4;,5-c]pyrrolidine Maleate. Arzneimittle-forschung 40:550-554; 1990.
11. 11. Fanselow, M. S. Conditional and unconditional components of postshock freezing. Pavlov. J. Biol. Sci. 15:177-182; 1980.
12. 12. Fanselow, M. S.; Helmstetter, F. J. Conditional analgesia, defensive freezing, and benzodiazepines. Behav. Neurosci. 102:233-243; 1988.
13. 13. Harvey, J. A.; Gormezano, I. Effects of haloperidol and pimozide on classical conditioning of the rabbit nictitating membrane response. J. Pharmacol. Exp. Ther. 218:712-719; 1981.
14. 14. Herman, J. P.; Guillonneau, D.; Dantzer, R.; Scatton, B.; Semerdjian-Rouquier, L.; Le Moal, M. Differential effects of inescapable foot shocks and of stimuli previously paired with inescapable foot shocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:2207-2214; 1982.
15. 15. Imperato, A.; Angelucci, L. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol. Bull. 25:383-389; 1989.
16. 16. Inoue, T.; Koyama, T.; Yamashita, I. Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol. Biochem. Behav. 44:371-374; 1993.
17. 17. Inoue, T.; Tsuchiya, K.; Koyama, T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol. Biochem. Behav. 49:911-920; 1994.
18. 18. Inoue, T.; Tsuchiya, K.; Koyama, T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol. Biochem. Behav. 53:825-831; 1996.
19. 19. King, D. J. The effect of neuroleptics on cognitive and psychomotor function. Br. J. Psychiatry 157:799-811; 1990.
20. 20. Koyama, T.; Matsubara, S.; Matsubara, R.; Inoue, T.; Yamashita, I. Preferential dopaminergic activation by clozapine in the medial prefrontal cortex: An in vivo microdialysis study. In: Moroji, T.; Yamamoto, K., eds. The biology of schizophrenia (Developments in Psychiatry, vol. 10). Amsterdam: Elsevier; 1994: 233-243.
21. 21. Litchfield, J. T., Jr.; Wilcoxon, F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113; 1949.
22. 2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J. Pharmacol. Exp. Ther. 265:498-508; 1993.
23. 23. McMillan, D. E. Determinants of drug effects on punished responding. Fed. Proc. 34:1870-1879; 1975.
24. 2 pKi values. J. Pharmacot. Exp. Ther. 251:238-246; 1989.
25. 25. Moghaddam, B.; Bunney, B. S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J. Neurochem. 54:1755-1760; 1990.
26. 26. Moore, N. A.; Tye, N. C.; Axton, M. S.; Risius, F. C. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J. Pharmacol. Exp. Ther. 262:545-551; 1992.
27. 27. Moore, N. A.; Calligaro, D. O.; Wong, D. T.; Bymaster, F.; Tye, N. C. The pharmacology of olanzapine and other new antipsychotic agents. Curr. Opin. Invest. Drugs 2:281-293; 1993.
28. 2 dopamine receptors. Eur. J. Pharmacol. 153:309-311; 1988.
29. 29. Overton, D. A. Experimental methods for the study of state-dependent learning. Fed. Proc. 33:1800-1813; 1974.
30. 30. Peroutka, S. J.; Snyder, S. H. Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am. J. Psychiatry 137:1518-1522; 1980.
31. 31. Pich, E. M.; Samanin, R. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine. Psychopharmacology (Berlin) 89:125-130; 1986.
32. 1A agonist, in three stress paradigms: Immobilization, forced swim and conditioned fear. Brain Res. 580:205-214; 1992.
33. 33. Russell, K. H.; Hagenmeyer-Houser, S. H.; Sanberg, P. R. Haloperidol-induced emotional defecation: A possible model for neuroleptic anxiety syndrome. Psychopharmacology (Berlin) 91: 45-49; 1987.
34. 2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-284; 1992.
35. 4 receptors elevated in schizophrenia. Nature 365:441-445; 1993.
36. 36. Spealman, R. D.; Katz, J.L. Some effects of clozapine on punished responding by mice and squirrel monkeys. J. Pharmacol. Exp. Ther. 212:435-440; 1980.
37. 37. Tamminga, C. A.; Gerlach, J. New neuroleptics and experimental antipsychotics in schizophrenia. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press: 1987:1129-1140.
38. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268:495-502; 1994.
39. 2 receptor binding to rat striatum. Eur. J. Pharmacol. 173:177-182; 1989.
40. 40. Thierry, A. M.; Tassin, J. P.; Blanc, G.; Glowinski, J. Selective activation of the mesocortical DA system by stress. Nature 263: 242-244; 1976.
41. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614; 1991.
42. 42. Wiley, J. L.; Compton, A. D.; Porter, J. H. Effects of four antipsychotics on punished responding in rats. Pharmacol. Biochem. Behav. 45:263-267; 1993.